Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion type Assertion NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_head.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion description "[The proliferation indexes in pseudolymphoma, which were calculated by using immunohistochemical analyses with anti-proliferating cell nuclear antigen and anti-MIB-1 monoclonal antibodies, were significantly lower than the indexes of MF, CTCL, BCL, and LyP, whereas, the apoptosis index in Lyp was significantly higher than in any other lymphoproliferative diseases studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_provenance.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion evidence source_evidence_literature NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_provenance.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion SIO_000772 9236520 NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_provenance.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion wasDerivedFrom befree-20140225 NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_provenance.
- NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_assertion wasGeneratedBy ECO_0000203 NP415429.RAKMV1e06X0bRMvKfGMNFsN8OYISciiWoyDshWaRVp2aI130_provenance.